Crewe Advisors LLC
- SEC CIK
- 0001730033
- Latest filing
- Jul 23, 2026
ALNY holding history
Alnylam Pharmaceuticals, Inc. in every 13F filed by Crewe Advisors LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
ALNY overviewAll 13F holders of ALNYFull Q2 2026 holdings
- Shares (Q4 2023)
- 0
- Sold out in Q4 2023
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 6
- Since Q2 2022
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q4 2023 | 0 | $0 | 0.0% | −1−100.0% | Sold out | Holders |
| Q3 2023 | 1 | $178 | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2023 | 1 | $190 | <0.1% | −26−96.3% | Reduced | Holders |
| Q1 2023 | 27 | $5.41K | <0.1% | −23−46.0% | Reduced | Holders |
| Q4 2022 | 50 | $11.9K | <0.1% | −36−41.9% | Reduced | Holders |
| Q3 2022 | 86 | $17.0K | <0.1% | +15+21.1% | Added | Holders |
| Q2 2022 | 71 | $10.0K | <0.1% | +71 | New | Holders |